Valuation: Alembic Pharmaceuticals Limited

Market Cap 164B 1.72B 1.49B 1.4B 1.28B 2.42B 2.45B 16.37B 6.42B 81.95B 6.46B 6.32B 273B P/E 2027 *
22.8x
P/E 2028 * 17.3x
Enterprise Value 174B 1.83B 1.59B 1.49B 1.36B 2.57B 2.6B 17.41B 6.83B 87.17B 6.88B 6.73B 290B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.73x
Free-Float
29.33%
Yield 2027 *
1.54%
Yield 2028 * 1.83%
1 day-0.16%
1 week+4.53%
Current month+4.53%
1 month+0.46%
3 months+7.29%
6 months+4.67%
Current year-1.54%
1 week 792.55
Extreme 792.55
851.85
1 month 787.4
Extreme 787.4
855.4
Current year 635.8
Extreme 635.8
855.4
1 year 635.8
Extreme 635.8
1,002
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 07/07/2025
Chief Tech/Sci/R&D Officer - 01/07/2023
Chief Operating Officer - 21/07/2025
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 50 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap.
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+4.53%-12.33%+5.02% 1.72B
+1.89%+3.20%+59.70%+165.18% 1,062B
-0.24%+0.45%+50.64%+52.02% 619B
-0.95%-5.26%+24.23%+65.08% 431B
+2.28%+3.20%+46.70%+37.60% 358B
+0.77%-1.26%+35.52%+40.54% 293B
+1.00%-6.84%+7.20%+8.62% 247B
-0.73%+4.44%+42.22%+66.41% 219B
+2.45%-11.27%+1.42%-44.69% 200B
-0.68%-0.32%+18.66%+66.32% 162B
Average +0.21%-1.32%+27.40%+46.21% 359.4B
Weighted average by Cap. -0.03%-0.82%+40.81%+77.79%

Financials

2027 *2028 *
Net sales 84.29B 885M 768M 719M 658M 1.24B 1.26B 8.41B 3.3B 42.12B 3.32B 3.25B 140B 92.31B 969M 841M 787M 720M 1.36B 1.38B 9.21B 3.62B 46.12B 3.64B 3.56B 154B
Net income 7.45B 78.23M 67.88M 63.57M 58.15M 110M 111M 744M 292M 3.72B 294M 287M 12.39B 9.53B 100M 86.85M 81.32M 74.39M 140M 142M 951M 373M 4.76B 376M 368M 15.85B
Net Debt 10.45B 110M 95.2M 89.15M 81.55M 154M 156M 1.04B 409M 5.22B 412M 403M 17.38B -4.24B -44.54M -38.65M -36.19M -33.11M -62.5M -63.32M -423M -166M -2.12B -167M -164M -7.06B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
07/08/26 832.15 -0.28% 76,380
06/08/26 ₹834.45 +1.99% 210,314
05/08/26 ₹818.20 +1.09% 243,621
04/08/26 ₹809.40 +0.45% 485,095
03/08/26 ₹805.75 +1.09% 58,590
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
834.45INR
Average target price
943.20INR
Spread / Average Target
+13.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock